Alfosbuvir

奥磷布韦

Report date: 2024/07/18 15:42:37
NME

Base Information

Drug NameAlfosbuvir
Drug Alias Name奥磷布韦HerbuvirAlfosbuvir和乐布韦alfosbuvir +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsHepatitis C, Chronic
Approved Indications in ChinaHepatitis C, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2023/05/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Sanhome Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Sanhome Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis C, Chronic
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A